arrow
N

Nadia Hindi

research health institute of fundacion jimenez diaz
H指数:32
被引数:5,132

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evolution of Treatment Strategies and Surgical Outcomes in Desmoid Tumors: A Retrospective Cohort Study

结节性筋膜炎的治疗策略演变与手术结果:一项回顾性队列研究

EJSO
IF2.9
2026-09-210
PRE
Biomarkers of prognosis and pazopanib response in soft tissue sarcoma: An exploratory analysis

软组织肉瘤的预后和帕唑帕尼治疗反应的生物标志物:一项探索性分析

2026-07-310
PRE
Sinonasal Sarcomas Management: An International Consensus Statement

鼻腔鼻窦肉瘤的管理:一项国际共识声明

2025-09-010
OAAI
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial
CANCER
IF5.1
2024-11-141
PRE
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma
2024-11-040
OAAI
Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor
2024-09-010
PRE
HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study
2024-05-172
OAAI
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN
2024-04-013
OAAI
Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma
2024-01-271
OAAI
Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain
2024-01-090
OAAI
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry
2023-12-016
OAAI
First in human trial of CEB-01 for retroperitoneal soft tissue sarcoma
2023-10-010
OA
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

REGISTRI: KIT/PDGFRA野生型转移性GIST的一线Regorafenib: 西班牙 (GEIS),意大利 (ISG) 和法国肉瘤组 (FSG) II期临床试验

2023-08-099
OAAI
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)
2023-04-0113
PRE